Strategic Blueprint, LLC

SEC CIK: 0001767821
Latest filing: Jul 23, 2026

SEC filings (opens in a new tab)

DFTX holding history

Definium Therapeutics, Inc. in every 13F filed by Strategic Blueprint, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DFTX overview All 13F holders of DFTX Full Q2 2026 holdings

Shares (Q3 2022): 0; Sold out in Q3 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2022

Holdings of DFTX by Strategic Blueprint, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2022	0	$0	0.0%	−1,867−100.0%	Sold outConverted for a 1-for-15 split	Holders
Q2 2022	28,000	$18.0K	<0.1%	+12,000+75.0%	Added	Holders
Q1 2022	16,000	$18.0K	<0.1%	+16,000	New	Holders